Counterfeiters Pounce on Coronavirus Fears, Federal Regulators Respond

Partner Libby Baney and director Matthew Rubin have written an article for the National Association of Boards of Pharmacies on the response of the U.S. government to counterfeiters taking advantage of the COVID-19 pandemic. The authors outline actions that federal agencies and authorities have taken to counter bad actors and counterfeiters flooding the web, online marketplaces, and social media forums with offers of COVID-19 cures, treatments, and medical supplies.